463 related articles for article (PubMed ID: 25837312)
1. Proteomics characterization of exosome cargo.
Schey KL; Luther JM; Rose KL
Methods; 2015 Oct; 87():75-82. PubMed ID: 25837312
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma.
Kalra H; Adda CG; Liem M; Ang CS; Mechler A; Simpson RJ; Hulett MD; Mathivanan S
Proteomics; 2013 Nov; 13(22):3354-64. PubMed ID: 24115447
[TBL] [Abstract][Full Text] [Related]
3. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
Xu R; Greening DW; Rai A; Ji H; Simpson RJ
Methods; 2015 Oct; 87():11-25. PubMed ID: 25890246
[TBL] [Abstract][Full Text] [Related]
4. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.
Lee YJ; Shin KJ; Jang HJ; Ryu JS; Lee CY; Yoon JH; Seo JK; Park S; Lee S; Je AR; Huh YH; Kong SY; Kwon T; Suh PG; Chae YC
Dev Cell; 2023 Feb; 58(4):320-334.e8. PubMed ID: 36800996
[TBL] [Abstract][Full Text] [Related]
5. Urinary extracellular microvesicles: isolation methods and prospects for urinary proteome.
Wang D; Sun W
Proteomics; 2014 Aug; 14(16):1922-32. PubMed ID: 24962155
[TBL] [Abstract][Full Text] [Related]
6. A method for the isolation and enrichment of purified bovine milk exosomes.
Vaswani K; Koh YQ; Almughlliq FB; Peiris HN; Mitchell MD
Reprod Biol; 2017 Dec; 17(4):341-348. PubMed ID: 29030127
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of exosomal cargo: the challenge of high purity vesicle isolation.
Abramowicz A; Widlak P; Pietrowska M
Mol Biosyst; 2016 Apr; 12(5):1407-19. PubMed ID: 27030573
[TBL] [Abstract][Full Text] [Related]
8. Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.
Tovar-Camargo OA; Toden S; Goel A
Expert Rev Mol Diagn; 2016; 16(5):553-67. PubMed ID: 26892862
[TBL] [Abstract][Full Text] [Related]
9. Identifying Urinary and Serum Exosome Biomarkers for Radiation Exposure Using a Data Dependent Acquisition and SWATH-MS Combined Workflow.
Kulkarni S; Koller A; Mani KM; Wen R; Alfieri A; Saha S; Wang J; Patel P; Bandeira N; Guha C; Chen EI
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):566-77. PubMed ID: 27485285
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Proteomics Analysis Reveals a Secretory Path- and Status-Dependent Signature of Exosomes Released from Tumor-Associated Macrophages.
Zhu Y; Chen X; Pan Q; Wang Y; Su S; Jiang C; Li Y; Xu N; Wu L; Lou X; Liu S
J Proteome Res; 2015 Oct; 14(10):4319-31. PubMed ID: 26312558
[TBL] [Abstract][Full Text] [Related]
11. Urinary exosomes and diabetic nephropathy: a proteomic approach.
Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
[TBL] [Abstract][Full Text] [Related]
12. Proteomic Characterization of Exosomes from HIV-1-Infected Cells.
Li M; Ramratnam B
Methods Mol Biol; 2016; 1354():311-26. PubMed ID: 26714721
[TBL] [Abstract][Full Text] [Related]
13. Redefining the Breast Cancer Exosome Proteome by Tandem Mass Tag Quantitative Proteomics and Multivariate Cluster Analysis.
Clark DJ; Fondrie WE; Liao Z; Hanson PI; Fulton A; Mao L; Yang AJ
Anal Chem; 2015 Oct; 87(20):10462-9. PubMed ID: 26378940
[TBL] [Abstract][Full Text] [Related]
14. Proteomics analysis of bladder cancer exosomes.
Welton JL; Khanna S; Giles PJ; Brennan P; Brewis IA; Staffurth J; Mason MD; Clayton A
Mol Cell Proteomics; 2010 Jun; 9(6):1324-38. PubMed ID: 20224111
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Wang Z; Hill S; Luther JM; Hachey DL; Schey KL
Proteomics; 2012 Jan; 12(2):329-38. PubMed ID: 22106071
[TBL] [Abstract][Full Text] [Related]
16. Exosomal proteome analysis of human plasma to monitor sepsis progression.
Xu Y; Ku X; Wu C; Cai C; Tang J; Yan W
Biochem Biophys Res Commun; 2018 May; 499(4):856-861. PubMed ID: 29625113
[TBL] [Abstract][Full Text] [Related]
17. Application of mass spectrometry in proteomics.
Guerrera IC; Kleiner O
Biosci Rep; 2005; 25(1-2):71-93. PubMed ID: 16222421
[TBL] [Abstract][Full Text] [Related]
18. Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry.
Jensen ON
Curr Opin Chem Biol; 2004 Feb; 8(1):33-41. PubMed ID: 15036154
[TBL] [Abstract][Full Text] [Related]
19. Urinary exosomal proteins as (pan-)cancer biomarkers: insights from the proteome.
Erozenci LA; Böttger F; Bijnsdorp IV; Jimenez CR
FEBS Lett; 2019 Jul; 593(13):1580-1597. PubMed ID: 31198995
[TBL] [Abstract][Full Text] [Related]
20. THE PRESENT AND FUTURE OF THE MASS SPECTROMETRY-BASED INVESTIGATION OF THE EXOSOME LANDSCAPE.
Xu L; Gimple RC; Lau WB; Lau B; Fei F; Shen Q; Liao X; Li Y; Wang W; He Y; Feng M; Bu H; Wang W; Zhou S
Mass Spectrom Rev; 2020 Sep; 39(5-6):745-762. PubMed ID: 32469100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
